Apixaban is a prescription anticoagulant medication containing of Apixaban. It belongs to a class of drugs known as Direct Oral Anticoagulants (DOACs) and specifically acts as a factor Xa inhibitor. It is used to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation and to treat or prevent deep vein thrombosis (DVT) and pulmonary embolism (PE). By "thinning" the blood, it helps prevent the formation of dangerous blood clots.

Apixaban is a highly selective, reversible, oral direct inhibitor of factor Xa, composed of Apixaban. It represents a modern advancement in antithrombotic therapy, offering a more predictable and convenient alternative to older anticoagulants like warfarin.

Composition and Mechanism: Each film-coated tablet contains of Apixaban. The medication works by directly inhibiting factor Xa, a key enzyme located at the convergence point of the intrinsic and extrinsic pathways of the coagulation cascade. By blocking factor Xa, Apixaban inhibits the conversion of prothrombin to thrombin. Since thrombin is the enzyme that converts fibrinogen to fibrin (the "mesh" that forms a clot), Apixaban effectively prevents thrombus formation and development.

Major Therapeutic Uses: The primary use of Apixaban is for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AFib). It is also used to treat Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), as well as to prevent recurrence of these conditions. Additionally, it is prescribed for thromboprophylaxis following hip or knee replacement surgery.

Benefits and Precautions: A significant benefit of Apixaban is that it does not require routine blood monitoring (like INR tests) or strict dietary restrictions. It has shown a lower risk of significant bleeding, particularly intracranial haemorrhage, compared to warfarin in many clinical settings. However, precautions are critical regarding bleeding risks because they prevent clotting, and even minor injuries can result in significant blood loss. It must be used with caution in patients with severe kidney or liver impairment.

Medical Supervision and Risks: Apixaban must be taken under strict medical supervision. Patients must be monitored for any signs of internal or external bleeding. The most significant risk is the potential for life-threatening haemorrhage. Furthermore, a "Black Box Warning" exists regarding the risk of spinal or epidural hematomas in patients receiving spinal anaesthesia, and the risk of thrombotic events if the medication is discontinued prematurely without a suitable replacement.

Apixaban (Apixaban 5mg) is indicated for:

Stroke Prevention:

Reducing the risk of stroke and blood clots in people with non-valvular atrial fibrillation.

DVT Treatment:

Treating blood clots in the veins of the legs (Deep Vein Thrombosis).

PE Treatment:

Treating blood clots in the lungs (Pulmonary Embolism).

Recurrence Prevention:

Preventing DVT and PE from happening again after initial treatment.

Post-Surgical Prophylaxis:

Preventing blood clots after hip or knee replacement surgery.

Apixaban provides a highly effective and predictable way to prevent life-threatening blood clots. By targeting Factor Xa directly, it offers a consistent level of anticoagulation that does not fluctuate with your diet or the intake of green leafy vegetables. This medicinal benefit allows patients to live a more normal lifestyle without the constant need for "blood-thinning" clinic visits or painful finger-prick tests.

One of the key advantages of the 5mg dose is its superior safety profile in preventing strokes compared to traditional therapies. Clinical studies have demonstrated that Apixaban is effective in preventing thromboembolism and carries a reduced risk of major bleeding complications, particularly intracranial haemorrhage. This makes it a preferred choice for elderly patients or those at higher risk of bleeding who still require robust protection against stroke.

Furthermore, Apixaban is highly convenient due to its rapid onset of action. It begins working within a few hours of the first dose, providing immediate protection. It also has a predictable "offset," meaning its effects wear off relatively quickly if it must be discontinued for planned surgery. For patients with Type 2 Diabetes or stable heart disease, Apixaban integrates well into complex medication regimens without the myriad of drug-drug interactions seen with older anticoagulants.

Common Side Effects (Generally mild):

• Minor Bleeding: Such as nosebleeds or bleeding from the gums when brushing teeth.

• Easy Bruising: Developing bruises from minor bumps or for no apparent reason.

• Nausea: Occasional stomach upset.

• Anaemia: Due to chronic minor blood loss, which may cause tiredness.

Uncommon Side Effects:

• Gastrointestinal Bleeding: Blood in the stool or vomit.

• Hematuria: Blood in the urine (pink or red urine).

• Hypotension: Low blood pressure, causing dizziness.

• Skin Rash: Mild allergic skin reactions.

Serious Side Effects (Requires immediate medical attention):

• Major Haemorrhage: Uncontrolled bleeding from any site.

• Intracranial Bleeding: Severe headache, sudden confusion, vision changes, or weakness on one side of the body.

• Internal Bleeding: Symptoms include "coffee-ground" vomit, black/tarry stools, or severe abdominal pain.

• Spinal Hematoma: Sudden tingling, numbness, or muscle weakness in the legs or back.

• Timing: Usually taken twice daily (morning and evening).

• Method: Swallow the tablet whole with a glass of water. If you have trouble swallowing, the tablet may be crushed and mixed with water or apple puree.
• With or Without Food: Apixaban can be taken with or without food.
• Consistency: It is vital to take this medication at the same time every day to ensure continuous protection against clots.
• Do Not Stop Abruptly: Stopping this medicine increases your risk of stroke. Only stop taking it if specifically instructed by your doctor.

Apixaban works through the "Direct Factor Xa Inhibition" pathway:

1. Selective Binding: Apixaban travels into the bloodstream and selectively binds to both free and clot-bound Factor Xa.
2. Thrombin Suppression: By blocking Factor Xa, the drug prevents the "prothrombinase complex" from forming, which stops the conversion of prothrombin to thrombin.
3. Clot Prevention: Since thrombin is the primary enzyme that creates fibrin (the building blocks of a clot) and activates platelets, its suppression ensures the blood remains fluid, and clots do not form.
4. No Direct Effect on Platelets: Unlike aspirin, it doesn't primarily inhibit platelet aggregation; it inhibits the formation of the chemical "glue" (fibrin).

• Soft Toothbrush: Use a soft-bristle toothbrush and waxed dental floss to reduce the risk of gum bleeding.

• Electric Razor: Use an electric shaver instead of a traditional blade to prevent nicks and cuts.

• Medical ID: Always carry a card or wear a bracelet that says "Taking Apixaban " so emergency responders are aware.

• Watch for "Hidden" Blood: Tell your doctor if you notice very dark, tarry stools or pink/red urine.

Store Apixaban at room temperature (20°C to 25°C). Keep the tablets in their original packaging to prevent moisture damage. Keep out of the reach of children.

• Grapefruit: Unlike some other medications, grapefruit does not have a clinically significant effect on Apixaban.
• St. John’s Wort: This herbal supplement can reduce the effectiveness of Apixaban, increasing your risk of a stroke. Avoid using it.

Aspirin / NSAIDs

SEVERE

Increases the risk of severe bleeding significantly. Avoid unless specifically prescribed by your doctor.

Ketoconazole

SEVERE

Can increase the levels of Apixaban in your body, leading to a higher risk of bleeding.

Rifampicin

MODERATE

Can decrease the levels of Apixaban, thereby reducing its effectiveness in preventing thrombosis.

Carbamazepine

MODERATE

May reduce the protection provided by Apixaban.

• Active Bleeding: Do not use if you have an active major bleed (e.g., a stomach ulcer or brain bleed).

• Kidney Disease: The dose may need to be reduced to 2.5mg if you meet specific criteria for renal impairment.

• Liver Disease: Use with caution; not recommended for patients with severe hepatic impairment.

• Artificial Heart Valves: Apixaban is contraindicated in patients with prosthetic heart valves.

The dosage is usually standardised but can be adjusted by your doctor.

• AFib Stroke Prevention: Typically twice daily.

• DVT/PE Treatment: Often begins with a higher dose for 7 days, followed by 5mg twice daily.

• Dose Reduction: Your doctor may reduce your dose to twice daily if you have at least two of the following: age above 80, weight below 60 kg, or high serum creatinine.

• Doctor's Direction: Never change your dose or stop the medication without medical guidance.

If you miss a dose, take it as soon as you remember on the same day. Resume your twice-daily schedule thereafter. Do not take two tablets at the same time to make up for a missed dose. If you are unsure, contact your doctor or pharmacist.